Changes in the incidence of melanoma in Australia, 2006-2021, by age group and ancestry: a modelling study.


Journal

The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 15 01 2024
accepted: 20 04 2024
medline: 1 9 2024
pubmed: 1 9 2024
entrez: 1 9 2024
Statut: ppublish

Résumé

To estimate the incidence of melanoma in Australia among people with ancestries associated with low, moderate, or high risk of melanoma, by sex and 5-year age group; to establish whether age-specific incidence rates by ancestry risk group have changed over time. Modelling study; United States (SEER database) melanoma incidence rates for representative ancestral populations and Australian census data (2006, 2011, 2016, 2021) used to estimate Australian melanoma incidence rates by ancestry-based risk. Australia, 2006-2021. Age-specific invasive melanoma incidence rates, and average annual percentage change (AAPC) in age-specific melanoma rates, by ancestry-based risk group, sex, and 5-year age group. The proportion of people in Australia who reported high risk (European) ancestry declined from 85.3% in 2006 to 71.1% in 2021. The estimated age-standardised melanoma incidence rate was higher for people with high risk ancestry (2021: males, 82.2 [95% confidence interval {CI}, 80.5-83.8] cases per 100 000 population; females, 58.5 [95% CI, 57.0-59.9] cases per 100 000 population) than for all Australians (males, 67.8 [95% CI, 66.5-69.2] cases per 100 000 population; females, 45.4 [95% CI, 44.3-46.5] cases per 100 000 population). AAPCs were consistently positive for Australians aged 50 years or older, both overall and for people with high risk ancestry, but were statistically significant only for some age groups beyond 65 years. AAPCs were negative for people aged 34 years or younger, but were generally not statistically significant. Melanoma incidence has declined in some younger age groups in Australia, including among people with high risk ancestry. Social and behavioural changes over the same period that lead to lower levels of ultraviolet radiation exposure probably contributed to these changes.

Identifiants

pubmed: 39217597
doi: 10.5694/mja2.52404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-257

Subventions

Organisme : National Health and Medical Research Council
ID : APP1185416, APP1155413

Informations de copyright

© 2024 The Author(s). Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.

Références

Arnold M, Singh D, Laversanne M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 2022; 158: 495‐503.
Fajuyigbe D, Lwin SM, Diffey BL, et al. Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes. FASEB J 2018; 32: 3700‐3706.
Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol 2016; 136: 1161‐1171.
Lancaster HO. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust 1956; 43: 1082‐1087.
Davis NC. Sunlight and melanomas. Lancet 1971; 1: 803.
Holman CD, James IR, Gattey PH, Armstrong BK. An analysis of trends in mortality from malignant melanoma in Australia. Int J Cancer 1980; 26: 703‐709.
Walker H, Maitland C, Tabbakh T, et al. Forty years of Slip! Slop! Slap! A call to action on skin cancer prevention for Australia. Public Health Res Pract 2022; 32: 31452117.
Tabbakh T, Volkov A, Wakefield M, Dobbinson S. Implementation of the SunSmart program and population sun protection behaviour in Melbourne, Australia: results from cross‐sectional summer surveys from 1987 to 2017. PLoS Med 2019; 16: e1002932.
Iannacone MR, Green AC. Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia. Melanoma Manag 2014; 1: 75‐84.
Olsen CM, Green AC, Pandeya N, Whiteman DC. Trends in melanoma incidence rates in eight susceptible populations through 2015. J Invest Dermatol 2019; 139: 1392‐1395.
Venugopal K, Youlden D, Marvelde LT, et al. Twenty years of melanoma in Victoria, Queensland, and South Australia (1997–2016). Cancer Epidemiol 2023; 83: 102321.
Australian Bureau of Statistics. Snapshot of Australia. A picture of the economic, social and cultural make‐up of Australia on Census Night, 10 August 2021. 28 June 2022. https://www.abs.gov.au/statistics/people/people‐and‐communities/snapshot‐australia/latest‐release (viewed July 2023).
Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol 2000; 42: 672‐674.
Czarnecki D. The incidence of melanoma is increasing in the susceptible young Australian population. Acta Derm Venereol 2014; 94: 539‐541.
Baade PD, Youlden DR, Youl P et al. Assessment of the effect of migration on melanoma incidence trends in Australia between 1982 and 2010 among people under 30. Acta Derm Venereol 2015; 95: 118‐120.
Czarnecki DD. Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia [letter]. Int J Cancer 2018; 143: 720‐721.
Aitken JF, Youlden DR, Baade PD et al. In response to: Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia [letter]. Int J Cancer 2018; 143: 722‐723.
Australian Institute of Health and Welfare. Data tables: CDIA 2023: Book 1a. Cancer incidence (age‐standardised rates and 5‐year age groups). In: Cancer data in Australia. Updated 31 Aug 2023. https://www.aihw.gov.au/reports/cancer/cancer‐data‐in‐australia/data (viewed Nov 2023).
Australian Bureau of Statistics. Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG). 18 Dec 2019. https://www.abs.gov.au/statistics/classifications/australian‐standard‐classification‐cultural‐and‐ethnic‐groups‐ascceg/latest‐release (viewed July 2023).
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence – seer research data, 17 registries, Nov 2022 Sub (2000–2020) – linked to county attributes – time dependent (1990–2021) income/rurality, 1969‐2020 counties, National Cancer Institute, Surveillance Research Program, released April 2023, based on the November 2022 submission. https://seer.cancer.gov/seerstat (viewed July 2023).
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394‐424.
International Agency for Research on Cancer (World Health Organization). Global Cancer Observatory: Cancer over time. https://gco.iarc.fr/overtime (viewed July 2023).
Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 1998; 47: 1‐16, 20.
Stats NZ. Estimated resident population (ERP) at 30 June 2018. https://statsnz.maps.arcgis.com/apps/MapSeries/index.html?appid=ab954d1f2e7a446a8a0195ccea440b85 (viewed Nov 2023).
Yu M, Baxter J. Australian children's screen time and participation in extracurricular activities. In: The Longitudinal Study of Australian Children annual statistical report 2015. Sept 2016. https://growingupinaustralia.gov.au/research‐findings/annual‐statistical‐report‐2015/australian‐childrens‐screen‐time‐and‐participation‐extracurricular (viewed Sept 2023).
Yang L, Cao C, Kantor ED, et al. Trends in sedentary behavior among the US population, 2001–2016. JAMA 2019; 321: 1587‐1597.
French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp Eye Res 2013; 114: 58‐68.
Dolgin E. The myopia boom. Nature 2015; 519: 276‐278.
French AN, Morgan IG, Burlutsky G, et al. Prevalence and 5‐ to 6‐year incidence and progression of myopia and hyperopia in Australian schoolchildren. Ophthalmology 2013; 120: 1482‐1491.
Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69‐82.
Petersen B, Triguero‐Mas M, Maier B, et al. Sun behaviour and personal UVR exposure among Europeans on short term holidays. J Photochem Photobiol B 2015; 151: 264‐269.
Memon A, Banniser P, Rogers I, et al. Changing epidemiology and age‐specific incidence of cutaneous malignant melanoma in England: an analysis of the national cancer registration data by age, gender and anatomical site, 1981–2018. Lancet Reg Health Eur 2021; 2: 100024.
Australian Bureau of Statistics. Measuring net undercount in the 2006 population census [information paper; 2940.0.55.001]. 7 May 2007. https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/2940.0.55.001Main+Features12007?OpenDocument (viewed July 2024).
United States Census Bureau. US Census Bureau guidance on the presentation and comparison of race and Hispanic origin data. 3 Dec 2021. https://www.census.gov/topics/population/hispanic‐origin/about/comparing‐race‐and‐hispanic‐origin.html (viewed July 2023).
Hu S, Parmet Y, Allen G, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 2009; 145: 1369‐1374.
Wang Y, Zhao Y, Ma S. Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer 2016; 16: 691.
Clairwood M, Ricketts J, Grant‐Kels J, Gonsalves L. Melanoma in skin of color in Connecticut: an analysis of melanoma incidence and stage at diagnosis in non‐Hispanic blacks, non‐Hispanic whites, and Hispanics. Int J Dermatol 2014; 53: 425‐433.

Auteurs

David C Whiteman (DC)

QIMR Berghofer Medical Research Institute, Brisbane, QLD.

Rachel E Neale (RE)

QIMR Berghofer Medical Research Institute, Brisbane, QLD.

Peter Baade (P)

Cancer Council Queensland, Brisbane, QLD.

Catherine M Olsen (CM)

QIMR Berghofer Medical Research Institute, Brisbane, QLD.

Nirmala Pandeya (N)

QIMR Berghofer Medical Research Institute, Brisbane, QLD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH